English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51072038    ???header.onlineuser??? :  993
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"su t h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 206-230 of 608  (25 Page(s) Totally)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T06:11:27Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:25Z Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L.
臺大學術典藏 2021-09-04T06:11:25Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:11:23Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:23Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:22Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L.
臺大學術典藏 2021-09-04T06:11:21Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:20Z Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model Li Y.-T.; Liu C.-J.; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.; Wu H.-L.
臺大學術典藏 2021-09-04T06:11:20Z Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis Yang H.-I.; Tseng T.-C.; Liu J.; Lee M.-H.; Liu C.-J.; Su T.-H.; Batrla-Utermann R.; Chan H.L.Y.; JIA-HORNG KAO; Chen C.-J.
臺大學術典藏 2021-09-04T06:11:18Z Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan Wang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; Su T.-H.; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:18Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:17Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:15Z Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues Tseng K.-C.; Tseng C.-W.; Hsieh T.-Y.; Peng C.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:10Z Reply Su T.-H.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:08Z Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus Su T.-H.; Liu C.-J.; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:08Z Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients Su T.-H.; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; Hsu S.-J.; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; Tseng T.-C.; Chen C.-L.; JIA-HORNG KAO; the C-TEAM study group; the Taiwan Liver Diseases Consortium
臺大學術典藏 2021-09-04T06:11:06Z High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments Nien H.-C.; Hsu S.-J.; Su T.-H.; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; JIA-HORNG KAO; Yang W.-S.
臺大學術典藏 2021-09-04T06:11:06Z Unmet Needs in Clinical and Basic Hepatitis B Virus Research Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:05Z Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in?chronic hepatitis B patients Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:05Z Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D Kao C.-N.; Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:04Z Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study Blach S.; Zeuzem S.; Manns M.; Altraif I.; Duberg A.-S.; Muljono D.H.; Waked I.; Alavian S.M.; Lee M.-H.; Negro F.; Abaalkhail F.; Abdou A.; Abdulla M.; Abou Rached A.; Aho I.; Akarca U.; Al Ghazzawi I.; Al Kaabi S.; Al Lawati F.; Al Namaani K.; Al Serkal Y.; Al-Busafi S.A.; Al-Dabal L.; Aleman S.; Alghamdi A.S.; Aljumah A.A.; Al-Romaihi H.E.; Andersson M.I.; Arendt V.; Arkkila P.; Assiri A.M.; Baatarkhuu O.; Bane A.; Ben-Ari Z.; Bergin C.; Bessone F.; Bihl F.; Bizri A.R.; Blachier M.; Blasco A.J.; Brandao Mello C.E.; Bruggmann P.; Brunton C.R.; Calinas F.; Chan H.L.Y.; Chaudhry A.; Cheinquer H.; Chen C.-J.; Chien R.-N.; Choi M.S.; Christensen P.B.; Chuang W.-L.; Chulanov V.; Cisneros L.; Clausen M.R.; Cramp M.E.; Craxi A.; Croes E.A.; Dalgard O.; Daruich J.R.; De Ledinghen V.; Dore G.J.; El-Sayed M.H.; Ergor G.; Esmat G.; Estes C.; Falconer K.; Farag E.; Ferraz M.L.G.; Ferreira P.R.; Flisiak R.; Frankova S.; Gamkrelidze I.; Gane E.; Garcia-Samaniego J.; Khan A.G.; Gountas I.; Goldis A.; Gottfredsson M.; Grebely J.; Gschwantler M.; Guimaraes Pessoa M.; Gunter J.; Hajarizadeh B.; Hajelssedig O.; Hamid S.; Hamoudi W.; Hatzakis A.; Himatt S.M.; Hofer H.; Hrstic I.; Hui Y.-T.; Hunyady B.; Idilman R.; Jafri W.; Jahis R.; Janjua N.Z.; Jar?u?ka P.; Jeruma A.; Jonasson J.G.; Kamel Y.; JIA-HORNG KAO; Kaymakoglu S.; Kershenobich D.; Khamis J.; Kim Y.S.; Kondili L.; Koutoubi Z.; Krajden M.; Krarup H.; Lai M.-S.; Laleman W.; Lao W.-C.; Lavanchy D.; Lazaro P.; Leleu H.; Lesi O.; Lesmana L.A.; Li M.; Liakina V.; Lim Y.-S.; Luksic B.; Mahomed A.; Maimets M.; Makara M.; Malu A.O.; Marinho R.T.; Marotta P.; Mauss S.; Memon M.S.; Mendes Correa M.C.; Mendez-Sanchez N.; Merat S.; Metwally A.M.; Mohamed R.; Moreno C.; Mourad F.H.; Mullhaupt B.; Murphy K.; Nde H.; Njouom R.; Nonkovic D.; Norris S.; Obekpa S.; Oguche S.; Olafsson S.; Oltman M.; Omede O.; Omuemu C.; Opare-Sem O.; Ovrehus A.L.H.; Owusu-Ofori S.; Oyunsuren T.S.; Papatheodoridis G.; Pasini K.; Peltekian K.M.; Phillips R.O.; Pimenov N.; Poustchi H.; Prabdial-Sing N.; Qureshi H.; Ramji A.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reesink H.W.; Ridruejo E.; Robbins S.; Roberts L.R.; Roberts S.K.; Rosenberg W.M.; Roudot-Thoraval F.; Ryder S.D.; Safadi R.; Sagalova O.; Salupere R.; Sanai F.M.; Sanchez Avila J.F.; Saraswat V.; Sarmento-Castro R.; Sarrazin C.; Schmelzer J.D.; Schreter I.; Seguin-Devaux C.; Shah S.R.; Sharara A.I.; Sharma M.; Shevaldin A.; Shiha G.E.; Sievert W.; Sonderup M.; Souliotis K.; Speiciene D.; Sperl J.; Starkel P.; Stauber R.E.; Stedman C.; Struck D.; Su T.-H.; Sypsa V.; Tan S.-S.; Tanaka J.; Thompson A.J.; Tolmane I.; Tomasiewicz K.; Valantinas J.; Van Damme P.; Van Der Meer A.J.; Van Thiel I.; Van Vlierberghe H.; Vince A.; Vogel W.; Wedemeyer H.; Weis N.; Wong V.W.S.; Yaghi C.; Yosry A.; Yuen M.-F.; Yunihastuti E.; Yusuf A.; Zuckerman E.; Razavi H.; The Polaris Observatory HCV Collaborators
臺大學術典藏 2021-09-04T06:11:03Z Surveillance of hepatocellular carcinoma by magnetic resonance imaging with liver-specific contrast Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:10:59Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:10:59Z Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up Chen H.-Y.; Su T.-H.; Tseng T.-C.; Yang W.-T.; Chen T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏 2021-09-04T06:10:58Z Strategies to manage hepatitis C virus infection disease burden—Volume 4 Chen D.S.; Hamoudi W.; Mustapha B.; Layden J.; Nersesov A.; Reic T.; Garcia V.; Rios C.; Mateva L.; Njoya O.; Al-Busafi S.A.; Abdelmageed M.K.; Abdulla M.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; Chen P.J.; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; JIA-HORNG KAO; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Luk?i? B.; Maaroufi A.; Malu A.O.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Nde H.; Ngige E.; Njouom R.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Rinke de Wit T.; Robbins S.; Roberts L.R.; Sanad S.J.; Sharma M.; Simonova M.; Su T.H.; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Schmelzer J.D.

Showing items 206-230 of 608  (25 Page(s) Totally)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
View [10|25|50] records per page